AS1810722 is primarily utilized in the field of medical research, particularly in the study of autoimmune diseases and inflammatory conditions. It functions as a selective inhibitor, targeting specific pathways involved in immune system regulation. This makes it a valuable tool for understanding the mechanisms underlying diseases such as rheumatoid arthritis and lupus. Additionally, it is being investigated for its potential therapeutic applications in modulating immune responses, which could lead to the development of novel treatments for chronic inflammatory disorders. Its role in preclinical studies also aids in identifying new drug targets and evaluating the efficacy of experimental therapies.